- Home
- XBIO vs STSS Comparison
XBIO vs STSS Comparison
Compare XBIO & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- STSS
- Stock Information
- Founded
- XBIO N/A
- STSS 2017
- Country
- XBIO United States
- STSS United States
- Employees
- XBIO N/A
- STSS N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- STSS Medical/Dental Instruments
- Sector
- XBIO Health Care
- STSS Health Care
- Exchange
- XBIO Nasdaq
- STSS Nasdaq
- Market Cap
- XBIO 5.6M
- STSS 5.8M
- IPO Year
- XBIO N/A
- STSS 2022
- Fundamental
- Price
- XBIO $3.66
- STSS $5.85
- Analyst Decision
- XBIO Hold
- STSS
- Analyst Count
- XBIO 1
- STSS 0
- Target Price
- XBIO N/A
- STSS N/A
- AVG Volume (30 Days)
- XBIO 192.9K
- STSS 48.3K
- Earning Date
- XBIO 08-12-2025
- STSS 08-13-2025
- Dividend Yield
- XBIO N/A
- STSS N/A
- EPS Growth
- XBIO N/A
- STSS N/A
- EPS
- XBIO N/A
- STSS N/A
- Revenue
- XBIO $2,582,728.00
- STSS N/A
- Revenue This Year
- XBIO $10.15
- STSS N/A
- Revenue Next Year
- XBIO $11.11
- STSS N/A
- P/E Ratio
- XBIO N/A
- STSS N/A
- Revenue Growth
- XBIO 5.63
- STSS N/A
- 52 Week Low
- XBIO $2.20
- STSS $3.36
- 52 Week High
- XBIO $5.27
- STSS $2,224.20
- Technical
- Relative Strength Index (RSI)
- XBIO 52.54
- STSS 47.31
- Support Level
- XBIO $3.49
- STSS $5.66
- Resistance Level
- XBIO $3.77
- STSS $6.00
- Average True Range (ATR)
- XBIO 0.41
- STSS 0.27
- MACD
- XBIO -0.04
- STSS 0.12
- Stochastic Oscillator
- XBIO 35.79
- STSS 78.87
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.